Clinical Trial for a dietary approach in Crohn's Disease
Details of Research
Contact:
Shlomit Boguslavsky, Clinical Research Coordinator
416-586-4800 x 8351
Shlomit.Boguslavsky@SinaiHealth.ca
Primary Investigator: Dr. Hillary Steinhart
Enrolment: Ongoing
Mount Sinai Hospital is participating in a research study to explore the effectiveness of the “Tasty&Healthy” dietary approach based on avoiding “pro-inflammatory” and processed ingredients, for inducing and maintaining remission in young adults.
We are looking for individuals:
- With Crohn’s Disease.
- Young adults aged 18-40
- Less than 3 years of disease duration
- In clinical remission or experiencing mild or moderate disease activity that warrants change in treatment
This study will last up to 24 weeks. Your Crohn’s Disease will be assessed and, if eligible, participants will be randomized into two randomized controlled trials both including the Tasty&Healthy dietary intervention for 8 weeks vs. 1) EEN (Modulen) in mild-moderate CD and vs. 2) a control group continuing their habitual diet. Responders from both trials will be offered to participate in an open label extension personalized-diet study of further 16 weeks (total 24 weeks). Reimbursement will be provided for study-related travel expenses and to assist in purchasing Tasty&Healthy foods.